VivoSeq
Other

Cycloserine

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Cycloserine is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

7/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

29

clinical trials

Completed23 · 79%
Unknown status3 · 10%
Withdrawn2 · 7%
Active, not recruiting1 · 3%

Clinical Trials

Trial Activity

29 trials

D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)
Active, not recruiting·—·Phase 2·NCT05591677·180 enrolled
D-Cycloserine+iTBS PK Study
Completed·UUniversity of Calgary·Phase 1·NCT05731323·12 enrolled
D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder
Completed·MMassachusetts General Hospital·Phase 1·NCT00842309·68 enrolled
D-Cycloserine to Enhance Extinction to Alcohol Cues
Completed·UUniversity of Georgia·N/A·NCT01362309·37 enrolled
Glycine and Oral D-Cycloserine in Alcoholic Patients and Healthy Subjects
Completed·YYale University·N/A·NCT00635102·57 enrolled
D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
Completed·—·Phase 3·NCT01102803·40 enrolled
The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear Healthy Controls.
Completed·UUniversity of Minnesota·N/A·NCT01733030·56 enrolled
Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia
Completed·—·Phase 3·NCT00515879·169 enrolled
Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
Completed·UUniversity of California, Los Angeles·N/A·NCT02582515·20 enrolled
D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD
Completed·NNew York State Psychiatric Institute·N/A·NCT01172873·16 enrolled
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Completed·NNYU Langone Health·Phase 4·NCT01981759·58 enrolled
The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
Completed·HHartford Hospital·Phase 2·NCT01361633·51 enrolled
D-Cycloserine Enhancement of Exposure in Social Phobia
Completed·MMassachusetts General Hospital·Phase 4·NCT00633984·169 enrolled
Cognitive Remediation With D-Cycloserine
Completed·MMassachusetts General Hospital·Phase 3·NCT01399866·150 enrolled
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
Completed·MMclean Hospital·Phase 1·NCT02304432·2 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)